From dealing with grief to treating a condition, healing can't come with just a magic pill.
News
Check out new positive topline results from the open-label phase 2A study of BPL-003 in participants with moderate-to-severe alcohol use disorder.
How does affluence impact mental health outcomes?
Neurocrine is initiating a phase 3 study of osavampator for the treatment of adults with major depressive disorder.
Let’s set the clock on Doomsday.
According to a new label update, the transfer of Qelbree into breastmilk is low.
Today is International Holocaust Remembrance Day.
Struggling with complex psychiatric diagnoses? Consider the diagnostic prism.
Here are highlights from this week in Psychiatric Times, including FDA approvals and conference coverage.
In this CME article, learn more about alternative methods to screen for lithium-related polyuria and how to implement amiloride for lithium-related polyuria.
When wicked problems arise, can we defy gravity?
Check out some of the top clinical pearls gleaned from presenters at Real Psychiatry.
Here's how best to manage polypharmacy in patients with traumatic brain injury.
Discover how psychiatry and creativity intertwine, exploring the link between mental health and artistic expression.
How can we prevent brain rot?
How often do you revisit a comprehensive medication reconciliation?
How does author Charles Fulton Oursler’s famous quote—'Many of us crucify ourselves between two thieves: regret for the past and fear of the future'—relates to modern cognitive behavioral therapy (CBT) and mindfulness?
Check out these top 10 best practices for treating patients with mood disorders.
Facing limited resources, cultural barriers, and complex mental health cases, A newly qualified doctor’s year in rural South Africa offers a deep dive into psychiatry in underserved areas.
Comparing the inaugural oath and the Hippocratic oath…
The FDA has approved the supplemental New Drug Application for Spravato, the first and only monotherapy for adults with treatment-resistant depression.
Check out the top 5 best practice recommendations for treating children and adolescents with psychotropic and combination therapies.
Does the psychiatric approach to treating women need to change? How does feminist thought consider psychiatric treatment? Linda Gask, Msc, PhD, shares her thoughts in "Out of Her Mind".
Check out these top tips for treating postpartum depression from the Real Psychiatry conference!
Digital therapeutics may help improve negative symptoms associated with schizophrenia.
Clinicians should consider rTMS as an intervention to alleviate OCD symptoms, especially in those who have failed other treatments or those with comorbid depression.
Here are highlights from this week in Psychiatric Times, including FDA approvals and trial updates.
A new report honoring Mohammad Ali and his compassion reminds us of our role in compassionate behaviors.
How do Eastern religions, spirituality, and cultural psychiatry shape our understanding of mental health?
Although iclepertin was found to be well tolerated, the agent did not meet endpoints.